Argenx Se (ARGX) Receivables - Other (2017 - 2025)
Argenx Se (ARGX) posted Receivables - Other of $464000.0 for Q4 2025, down 91.81% on a QoQ basis from $5.7 million in Q4 2024, and down 91.81% year-over-year from $5.7 million in Q4 2024.
Argenx Se (ARGX) Receivables - Other (2017 - 2025) Analysis & Trends
Argenx Se's Receivables - Other history runs 9 years deep, the most recent figure standing at $464000.0 for Q4 2025.
- Quarterly Receivables - Other fell 91.81% year-over-year to $464000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $464000.0 (down 91.81% YoY) and the FY2025 annual result came in at $464000.0, down 91.81% from the prior year.
- Receivables - Other was $464000.0 for Q4 2025 at Argenx Se, down from $5.7 million in the prior quarter.
- Across five years, Receivables - Other topped out at $5.7 million in Q4 2024 and bottomed at $464000.0 in Q4 2025.
- A 5-year average of $2.0 million and a median of $1.0 million in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2024 — Receivables - Other surged 188.69% — and 2025, when it plunged 91.81%.
- Argenx Se's Receivables - Other stood at $864000.0 in 2021, then climbed by 18.63% to $1.0 million in 2022, then surged by 91.41% to $2.0 million in 2023, then surged by 188.69% to $5.7 million in 2024, then plunged by 91.81% to $464000.0 in 2025.
- Business Quant data shows ARGX's Receivables - Other at $464000.0 in Q4 2025, $5.7 million in Q4 2024, and $2.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 464,000.00 |
| Dec 31, 2025 | 464,000.00 |
| Dec 31, 2024 | 5.66 Mn |
| Dec 31, 2024 | 5.66 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 1.03 Mn |
| Dec 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 864,000.00 |
| Dec 31, 2021 | 864,000.00 |
| Dec 31, 2020 | 5.54 Mn |
| Dec 31, 2020 | 5.54 Mn |
| Dec 31, 2019 | 3.82 Mn |
| Dec 31, 2019 | 3.82 Mn |
| Dec 31, 2018 | 2.42 Mn |
| Dec 31, 2018 | 2.42 Mn |
| Dec 31, 2017 | 883,074.39 |
| Dec 31, 2017 | 883,074.39 |